Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 4 minute read General business news Veranda Learning caps FY25 with Rs 500cr revenue, EBITDA surges 59% amid strategic reset Veranda Learning hits ₹500 Cr in FY25 revenue; see how strategic resets and new acquisitions are shaping its long-term future. byPallavi MadhirajuMay 28, 2025